Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Galderisi M, de Simone G, D'Errico A, Sidiropulos M, Viceconti R, Chinali M, Mondillo S, de Divitiis O.
Coronary flow reserve in coronary artery disease is feasible, useful, and prognostically validated tool to be considered with standard wall motion analysis; It is currently recommended as the state-of-the art method with vasodilatory stress echocardiography when adequate technology and expertise are available. Its non-invasive, radiation-free nature also make it ideally suited for ethically immaculate, radiation-free research-oriented studies, especially when each subject or patient acts as his/her own control, allowing establishment of acute or chronic changes in coronary flow reserve, induced, for instance, by acute food or beverage intake (such as alcohol or chocolate) or ingestion of medication in chronic therapeutic interventions, for instance, antihypertensive drugs.
Reference: Am J Hypertens 2008;21:1040-6
Bombardini T, Nevola E, Giorgetti A, Landi P, Picano E, Neglia
Coronary blood flow increases three- to fourhold in normal subjects, but the reduction in diastolic time (much greater than shortening in systolic time) limits mostly the perfusion in the subendocardial layer – whose perfusion is mainly diastolic, whereas the perfusion in the subepicardial layer is also systolic.
Reference: J Nucl Cardiol 2008;15:353-62
© 2017 European Society of Cardiology. All rights reserved